Product Information
TELMISARTAN 80 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1485 per EA under NDC 67877048430. Its NADAC has been published 343 times since Dec 4, 2019.
Strength
80 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877048430
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA205150On Market Since
6/12/2016
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 80 MG TABLET has been published 343 times since Dec 4, 2019, and over the history we have for it it has declined 73.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1485 per EA |
|---|---|
| All-time high | $0.6664 (Mar 11, 2020) |
| All-time low | $0.1345 (May 22, 2024) |
| 52-week high | $0.1634 |
| 52-week low | $0.1485 |
| Median price | $0.2680 |
| Average price | $0.2954 |
| Largest weekly change | +53.7% (Nov 22, 2023) |
| Weeks tracked | 343 |
| Tracking since | Dec 4, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TELMISARTAN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1485 per EA (NDC 67877048430), effective Jun 24, 2026.
How has the price of TELMISARTAN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 73.1%. It has been tracked across 343 weekly CMS publications since Dec 4, 2019.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?
Since Dec 4, 2019, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.1345 (May 22, 2024) to a high of $0.6664 (Mar 11, 2020), with a median of $0.2680 per EA.
Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TELMISARTAN 80 MG TABLET, but none are currently priced below it.
Who manufactures TELMISARTAN 80 MG TABLET?
TELMISARTAN 80 MG TABLET (NDC 67877048430) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification